Monitoring Important With Antidepressants for Alcohol Use Disorder
By Elana Gotkine HealthDay Reporter
MONDAY, Aug. 5, 2024 -- For patients with alcohol use disorder (AUD) treated with antidepressants, those who achieve a reduction in depression symptoms have fewer relapses over time, according to a study published online July 26 in Alcohol: Clinical & Experimental Research.
Joshua Jaeger, from the University of Bern in Switzerland, and colleagues examined the relationship between antidepressant medication and changes in depression symptoms and alcohol use among 153 detoxified AUD patients who attended a 12-week residential treatment program between 2015 and 2019. To assess the role of changes in depression symptoms as a mediating factor, the total, direct, and mediated effects of antidepressants were estimated on the percentage of days abstinent.
The researchers identified a dual impact pathway model in the mediation analysis, with antidepressants having a significantly negative direct effect on abstinence and a significantly positive indirect effect, which was mediated via reduction of depression symptoms.
"Our findings call for personalized clinical decision-making based on vigilant monitoring of depression symptoms, and adopting tailored treatment approaches to optimize AUD treatment outcomes," the authors write. "Given the frequent co-occurrence of AUD and depression symptoms and their treatment with antidepressant medication, our study offers potential implications for everyday clinical practice and calls for further investigation of the dual pathway hypothesis in diverse settings and populations."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
Gender-Affirming Hormone Therapy in Primary Care Tied to Reduced Depressive Symptoms
MONDAY, March 24, 2025 -- Gender-affirming hormone therapy (GAHT) in primary care is associated with lower rates of moderate-to-severe depressive symptoms in U.S. transgender...
Exposure to Maternal Cannabis Use Disorder Ups Risk for Youth Behavioral Disorders
MONDAY, March 24, 2025 -- Children exposed to maternal cannabis use disorder (CUD) during pregnancy and postpartum have an increased risk for later behavioral disorders, according...
Total Injury Death Rate Increased From 2013 to 2021, Followed by Decline
THURSDAY, March 20, 2025 -- The total injury death rate in the United States increased from 2013 through 2021, then declined through 2023, according to a March data brief...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.